Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Patent
1996-06-05
1999-12-07
Mosher, Mary E.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant virus encoding one or more heterologous proteins...
4242301, 4242321, 435235, 435 693, 435 691, 4353201, A61K 39245, A61K 39285, C12N 1500, C12N 701
Patent
active
059978783
ABSTRACT:
Attenuated recombinant viruses containing DNA encoding an HCMV antigen, as well as methods and compositions employing the viruses, expression products therefrom, and antibodies generated from the viruses or expression products, are disclosed and claimed. The recombinant viruses can be NYVAC or ALVAC recombinant viruses. The recombinant viruses and gene products therefrom and antibodies generated by the viruses and gene products have several preventive, therapeutic and diagnostic uses. The DNA of the recombinant viruses can be used as probes or for generating PCR primers.
REFERENCES:
patent: 5494807 (1996-02-01), Paoletti et al.
Gehrz et al, 1992, Antivival Rej., vol. 17, pp. 115-131.
Tartaglia et al, 1992, Virology, vol. 188, pp. 217-232.
Perkus et al, 1985, Science, vol. 229, pp. 981-984.
Qadri et al, 1992, J. Gen. Virology, vol. 73, pp. 2913-2921.
Cox William I.
Kauffman Elizabeth B.
Paoletti Enzo
Pincus Steven E.
Connaught Laboratories
Mosher Mary E.
Salimi Ali R.
LandOfFree
Recombinant poxvirus-cytomegalovirus, compositions and uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant poxvirus-cytomegalovirus, compositions and uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant poxvirus-cytomegalovirus, compositions and uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-820685